Man, Alice http://orcid.org/0000-0002-8011-1864
Groeneweg, Gabriella S. S.
Ross, Colin J. D. http://orcid.org/0000-0003-1476-7037
Carleton, Bruce C. http://orcid.org/0000-0002-4485-4054
Article History
Accepted: 26 February 2024
First Online: 14 March 2024
Declarations
:
: No funding was received for the preparation of this manuscript.
: Bruce C. Carleton and Colin J.D. Ross receive federal grant funds from the Canadian Institutes of Health Research, Genome Canada, and Genome BC, with additional support provided by the British Columbia Provincial Health Services Authority, BC Children's Hospital Foundation, and Health Canada. They have also previously received research funding from Dynacare Next Specialized Diagnostics as part of a Genome Canada federal grant. Gabriella S.S. Groeneweg provides program management of these research funds. Bruce C. Carleton also receives federal grant funds from the US Centers for Disease Control and Prevention, and in the past 3 years has provided consultation services to the Canadian Agency for Drugs and Technologies in Health and Dynacare. Alice Man declares no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: AM contributed to the conceptualization, literature search, and writing of the original draft. BCC played a supervisory role and contributed to the conceptualization and writing of the original draft. AM, BCC, CJDR, and GSSG contributed to the review and editing of the manuscript. All authors read and approved the final manuscript.